KaloBios Pharmaceuticals Inc., the company majority owned by controversial biotech investor Martin Shkreli, filed for Chapter 11 bankruptcy protection with a Delaware bankruptcy court late Tuesday. That filing came just hours after the company KBIO, -5 … Read the full article on MarketWatch »
Martin Shkreli"s KaloBios files for bankruptcy - MarketWatch
No comments:
Post a Comment